1	9 Patients on miglustat at the start of the study will be excluded if the dose of miglustat can not be held constant for the duration of the study The miglustat dose must have been constant for two months prior to the baseline NIH evaluation Patients will be withdrawn if they initiate miglustat use after|miglustat[14,23]|||||||two months[194,204]||C1321596|402316|402316|miglustat
1	9 Patients on miglustat at the start of the study will be excluded if the dose of miglustat can not be held constant for the duration of the study The miglustat dose must have been constant for two months prior to the baseline NIH evaluation Patients will be withdrawn if they initiate miglustat use after|miglustat[82,91]|||||||||C1321596|402316|402316|miglustat
1	9 Patients on miglustat at the start of the study will be excluded if the dose of miglustat can not be held constant for the duration of the study The miglustat dose must have been constant for two months prior to the baseline NIH evaluation Patients will be withdrawn if they initiate miglustat use after|miglustat[151,160]|||||||||C1321596|402316|402316|miglustat
1	9 Patients on miglustat at the start of the study will be excluded if the dose of miglustat can not be held constant for the duration of the study The miglustat dose must have been constant for two months prior to the baseline NIH evaluation Patients will be withdrawn if they initiate miglustat use after|miglustat[286,295]|||||||||C1321596|402316|402316|miglustat
